The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHome Reit Regulatory News (HOME)

  • This share is currently suspended. It was suspended at a price of 38.014

Share Price Information for Home Reit (HOME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.014
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 38.014
HOME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to announcement by Bluestar

11 May 2023 18:22

RNS Number : 1719Z
Home REIT PLC
11 May 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

11 May 2023

Home REIT plc

 

("Home REIT" or the "Company")

 

Response to announcement by Bluestar Group Limited ("Bluestar") and update regarding Review of Strategic Options

The Board of Home REIT notes the announcements by Bluestar on 10 and 11 May 2023. The Board met on the morning of 10 May 2023 to formally consider the PUSU extension request received from Bluestar on 5 May 2023 and has given further careful consideration to its position following receipt of further information from Bluestar and feedback from shareholders.

The Board believes that progressing Bluestar's proposal at this time is unlikely to maximise value for shareholders. The Board and its financial adviser have given particular consideration to the significant uncertainties in relation to the deliverability of Bluestar's non-binding and indicative proposal, including its key valuation assumptions, extensive due diligence requirements and extremely limited information on its financing. The Board's immediate concern is to complete the appointment of a new investment adviser in order to stabilise the Company's property portfolio and maximise value for shareholders, while at all times prioritising the interests of the occupants of the Company's properties. The Board will not proactively pursue a sale of the Company at this time and therefore this part of the review of strategic options announced on 16 February 2023 is now concluded. The Board and its new investment adviser, when appointed, will continue to monitor this position, in particular once it is in possession of a new property valuation.

The Board notes that, as set out in Bluestar's announcement earlier today, under note 2 of Rule 2.8 of the Takeover Code (the "Code"), Bluestar has the right to set aside the restrictions of Rule 2.8 with the agreement of the Board, following the announcement of a firm intention to make an offer for Home REIT by or on behalf of a third party, if Home REIT announces a Rule 9 waiver or a reverse takeover, or the Panel on Takeovers and Mergers has determined that there has been a material change of circumstances.

The Company is now no longer in an offer period under the Takeover Code.

A further announcement in relation to the appointment of a new investment adviser is expected to be made in the near term.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

 

Smith Square Partners (Financial Adviser) John Craven

Toby Rolls

 

+44 (0)20 3696 7260

 

FTI Consulting (Communications Adviser)

Dido Laurimore

Eve Kirmatzis

Ellie Perham-Marchant

Oliver Harrison

HomeREIT@fticonsulting.com

+44 (0)20 3727 1000 

 

The Company's LEI is: 213800A53AOVH3FCGG44.

 

For more information, please visit the Company's website: www.homereituk.com

 

Inside Information

The information contained within this announcement is deemed by Home REIT to constitute inside information as stipulated under the Market Abuse Regulation (EU) no. 596/2014 (as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018). On the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Disclaimer

Smith Square Partners LLP ("Smith Square"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting for Home REIT and no one else in connection with the matters set out in this Announcement. In connection with such matters, Smith Square will not regard any other person as its client and will not be responsible to any persons other than Home REIT for providing the protections afforded to clients of Smith Square, or for providing advice in relation to the contents of this announcement or any other matter referred to herein. Smith Square does not owe or accept any duty, liability or responsibility whatsoever (whether direct, indirect, consequential, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Smith Square in connection with this announcement, in any statement contained herein or otherwise.

Publication of this announcement

In accordance with Rule 26.1 of the Code, a copy of this announcement will be available, subject to certain restrictions relating to persons resident in restricted jurisdictions, on Home REIT's website at https://www.homereituk.com/possible-offer/ no later than 12 noon on 12 May 2023.

The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RSPABMRTMTTBBBJ
Date   Source Headline
25th Apr 20224:27 pmRNSHolding(s) in Company
21st Apr 20225:30 pmRNSHolding(s) in Company
10th Mar 202211:11 amRNSINVESTMENT ADVISER UPDATE
8th Mar 20229:24 amRNSHolding(s) in Company
9th Feb 20223:06 pmRNSPUBLICATION OF SUPPLEMENTARY PROSPECTUS
27th Jan 20223:31 pmRNSResult of AGM
27th Jan 20222:30 pmRNSDividend Declaration
25th Jan 20227:00 amRNSNET PROCEEDS OF £350M EQUITY ISSUE FULLY DEPLOYED
4th Jan 202210:17 amRNSHolding(s) in Company
23rd Dec 20212:33 pmRNSHolding(s) in Company
21st Dec 20214:44 pmRNSHolding(s) in Company
21st Dec 202110:25 amRNSHolding(s) in Company
17th Dec 20217:00 amRNSFURTHER £60M DEPLOYED FOLLOWING EQUITY ISSUE
2nd Dec 20219:44 amRNSHolding(s) in Company
2nd Dec 20217:00 amRNSNEW 15-YEAR TERM £130 MILLION DEBT FACILITY AGREED
23rd Nov 20215:57 pmRNSHolding(s) in Company
23rd Nov 20213:29 pmRNSDirector Declaration
18th Nov 20215:55 pmRNSHolding(s) in Company
17th Nov 20215:53 pmRNSHolding(s) in Company
11th Nov 20217:01 amRNSAcquisitions
11th Nov 20217:00 amRNSFinal Results
5th Nov 20211:47 pmRNSNotice of Results
1st Nov 202111:57 amRNSHolding(s) in Company
18th Oct 20217:00 amRNS£166.4 MILLION OF ACQUISITIONS
15th Oct 20213:13 pmRNSHolding(s) in Company
1st Oct 20216:09 pmRNSHolding(s) in Company - Replacement
1st Oct 20217:00 amRNSTotal Voting Rights
29th Sep 20216:08 pmRNSHolding(s) in Company
29th Sep 202111:25 amRNSHolding(s) in Company
29th Sep 202111:12 amRNSHolding(s) in Company
29th Sep 202111:05 amRNSHolding(s) in Company
28th Sep 20215:34 pmRNSHolding(s) in Company
28th Sep 20215:26 pmRNSHolding(s) in Company
28th Sep 20215:17 pmRNSHolding(s) in Company
27th Sep 20215:42 pmRNSDirector/PDMR Shareholdings
27th Sep 202111:47 amRNSHolding(s) in Company
23rd Sep 20217:00 amRNSResults of Oversubscribed Initial Issue
20th Sep 20211:15 pmRNSResult of General Meeting
17th Sep 20213:45 pmRNSHolding(s) in Company
15th Sep 20217:00 amRNSINTERIM DIVIDEND DECLARATION
2nd Sep 20215:55 pmRNSPublication of Prospectus and Circular
31st Aug 20217:01 amRNSLaunch of Issue & Placing Programme
31st Aug 20217:00 amRNSTrading Update
20th Jul 20217:00 amRNSPOTENTIAL EQUITY ISSUE
3rd Jun 20217:00 amRNSAcquisitions
20th May 20211:24 pmRNSInterim dividend declaration
18th May 20213:36 pmRNSHolding(s) in Company
11th May 202112:48 pmRNSHolding(s) in Company
28th Apr 20217:00 amRNSMaiden interim results to 28 February 2021
19th Apr 202110:00 amRNSNotice of Results for period to 28 February 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.